Главная
Рынки
Графики и идеи
Алготрейдинг
Новости
Store
Брокеры
Скачать
Экономический календарь
Торговые сигналы
Вебтерминал
Нажмите
/
для поиска: @user, $symbol, ...
Поиск
Вход
Создать аккаунт
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HRMY
#1797
Harmony Biosciences Holdings, Inc. Common Stock
28.540
0
+0.25%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
Годовой диапазон
Дневное изменение
+0.25%
Месячное изменение
-24.24%
6-месячное изменение
-7.64%
Годовое изменение
-7.64%
Предыдущее закрытие
28.470
0
Open
28.540
0
Bid
Ask
Low
28.540
0
High
28.540
0
Объем
110
Рынки
Рынок акций США
Здравоохранение
HRMY
Open full chart
Financials
Overview
Отчетность
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
56.89 M
58.87 M
59.62 M
56.77 M
57.35 M
57.84 M
—
Valuation ratios
Enterprise value
1.83 B
2.28 B
2.91 B
1.44 B
1.52 B
1.41 B
5.04 B
Price to earnings ratio
14.58
73.52
17.83
14.46
13.71
13.81
45.34
Price to sales ratio
5.83
8.27
7.39
3.19
2.79
2.52
9.44
Price to cash flow ratio
-312.12
25.61
22.4
8.47
9.06
6.29
27.43
Price to book ratio
9.59
13.54
8.03
3.98
3.02
2.52
4.49
Enterprise value to EBITDA ratio
61.68
20.96
20.12
6.62
7.12
6.1
20.5
Profitability ratios
Return on assets %
0.09
0.08
0.27
0.16
0.15
0.12
0.14
Return on equity %
0.38
0.19
0.45
0.28
0.22
0.18
0.2
Return on invested capital %
25.57
193.23
56.92
157.94
129.43
141.66
124.81
Gross margin %
82.64
81.82
80.93
79.17
78.06
77.16
310.62
Operating margin %
10.63
28.66
27.45
32.99
26.7
24
97.64
EBITDA margin %
18.55
35.56
33.07
37.27
29.85
26.65
115.7
Net margin %
23.13
11.33
41.44
22.14
20.36
18.27
74.97
Liquidity ratios
Quick ratio
1.93
5.21
5.02
2.72
3.27
3.58
14.74
Current ratio
1.95
5.29
5.07
2.75
3.31
3.6
14.86
Inventory turnover
7.26
13.45
19.13
25.1
24.97
31.6
31.21
Asset turnover
0.37
0.71
0.79
0.78
0.79
0.76
0.77
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.45
0.44
0.28
0.22
0.16
0.11
0.52
Long term debt to total equity ratio
2
1.02
0.47
0.38
0.25
0.17
0.76
Per share metrics
Operating cash flow per share
0.12
1.66
2.36
3.63
3.8
5.95
5.95
EBIT per share
0.66
1.48
1.97
3.18
3.3
3.56
3.56
EBITDA per share
1.15
1.83
2.37
3.59
3.69
3.95
4.26
Total debt per share
—
—
—
—
—
—
—
Cash per share
8.87
3.96
5.29
5.85
8.07
13.24
43.04
Net current asset value per share
10.2
4.8
6.55
7.47
10.01
15.49
52.59
Tangible book value per share
-2.53
0.72
3.96
5.46
9.43
13.34
47.91
Working capital per share
4.98
3.9
5.26
4.76
6.98
11.19
38.41
Book value per share
3.77
3.15
6.59
7.74
11.39
14.86
54.63
Новости
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y
IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
Corcept's Q4 Earnings and Revenues Fall Short of Estimates
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y
Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y
UBS снижает целевую цену Harmony Biosciences из-за раннего выхода дженериков Wakix
UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry
Truist подтверждает рейтинг Hold для Harmony Biosciences, цель $25
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target
AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales
BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market